Vitamin D and Type 2 Diabetes - Treat-To-Target
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07448974
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose other
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT07448974
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07448974. Randomized; quadruple masking; primary purpose other. Start 2026-08-04 (actual); primary completion 2030-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vitamin D and Type 2 Diabetes - Treat-To-Target
- Acronym
- D2d-TTT
- Condition
- Prediabetes
- Condition
- Type 2 Diabetes (T2DM)
- Intervention (Drug)
- Vitamin D (Cholecalciferol )
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tufts Medical Center
- Collaborator
- Abiogen Pharma
Record details
- Record id
cardio:ct-nct07448974- Content hash
2a0b1aea63ccb028036f53b95077f9864eb51eb9a8c94bd2f127d54a09a6a5bd